Statement of Changes in Beneficial Ownership (4)
January 25 2022 - 6:15PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Whitton Peter |
2. Issuer Name and Ticker or Trading Symbol
Bakhu Holdings, Corp.
[
BKUH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
3 COPLOW CRESCENT |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/22/2021 |
(Street)
SYSTON LEICESTER, X0 LE7 2JE
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 9/22/2021 | 9/22/2021 | S | | 71429 | A | $0 | 87626882 (1) | D | |
Series A Preferred Stock | | | | | | | | 4 | I | Cell Science Holding Ltd. (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option | $5.1 | | | | | | | 9/22/2020 | 9/22/2027 | Common Stock | 100000 | | 100000 | D | |
Explanation of Responses: |
(1) | Consists of (a) 126,882 shares of Common Stock Owned directly by Mr. Whitton and (b) 87,500,000 shares of Common Stock owned by Mentone Ltd. Mr. Whitton is the owner of 34% of Mentone Ltd., and is deemed to be the beneficial owner of the shares of Common Stock owned by Mentone Ltd. |
(2) | Cell Science Holding Ltd. is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned by Inter-M Traders FZ LLE (40%), OZ Corporation (30%) and Mentone Ltd., 30%. Mr. Whitton is the owner of 34% of Mentone Ltd., and is deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock owned by Cell Science. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Whitton Peter 3 COPLOW CRESCENT SYSTON LEICESTER, X0 LE7 2JE | X | X |
|
|
Signatures
|
Peter Whitton | | 1/25/2022 |
**Signature of Reporting Person | Date |
Bakhu (PK) (USOTC:BKUH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bakhu (PK) (USOTC:BKUH)
Historical Stock Chart
From Jul 2023 to Jul 2024